{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:47:52Z","timestamp":1774532872789,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,24]]},"DOI":"10.7759\/cureus.18245","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T12:08:45Z","timestamp":1708690125000},"source":"Crossref","is-referenced-by-count":4,"title":["An Emerging Facet of Diabetes Mellitus: The Nexus of Gastrointestinal Disorders"],"prefix":"10.7759","author":[{"given":"Srimy","family":"Modi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naqvi","family":"Syed Gaggatur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliya H","family":"Sange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubashira K","family":"Sarnaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harini","family":"Gajjela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Sange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Diagnosis and classification of diabetes mellitus","volume":"1","author":"American Diabetes Association","year":"2006","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006, 1:43-8.","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho NH","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018, 138:271-81. 10.1016\/j.diabres.2018.02.023","journal-title":"Diabetes Res Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo RA","year":"2009","unstructured":"Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009, 58:773-95. 10.2337\/db09-9028","journal-title":"Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115997","article-title":"Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study","volume":"90","author":"Magnusson I","year":"1992","unstructured":"Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest. 1992, 90:1323-7. 10.1172\/JCI115997","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman GI","year":"2014","unstructured":"Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014, 371:1131-41. 10.1056\/NEJMra1011035","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.1.131","article-title":"Management of hyperglycemic crises in patients with diabetes","volume":"24","author":"Kitabchi AE","year":"2001","unstructured":"Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM. Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001, 24:131-53. 10.2337\/diacare.24.1.131","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-S005","article-title":"Classification and diagnosis of diabetes","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015, 38:S8-16. 10.2337\/dc15-S005","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998, 352:837-53. 10.1016\/S0140-6736(98)07019-6","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2014.0069","article-title":"The treatment of type 2 diabetes","volume":"111","author":"Pfeiffer AF","year":"2014","unstructured":"Pfeiffer AF, Klein HH. The treatment of type 2 diabetes. Dtsch Arztebl Int. 2014, 111:69-81. 10.3238\/arztebl.2014.0069","journal-title":"Dtsch Arztebl Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2004.09.004","article-title":"Advanced glycation endproducts--role in pathology of diabetic complications","volume":"67","author":"Ahmed N","year":"2005","unstructured":"Ahmed N. Advanced glycation endproducts--role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005, 67:3-21. 10.1016\/j.diabres.2004.09.004","journal-title":"Diabetes Res Clin Pract"},{"key":"ref11","article-title":"Diabetes mellitus: management of gastrointestinal complications","volume":"15","author":"Careyva B","year":"2016","unstructured":"Careyva B, Stello B. Diabetes mellitus: management of gastrointestinal complications. Am Fam Physician. 2016, 15:980-6.","journal-title":"Am Fam Physician"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/67961","article-title":"Gastrointestinal complications in patients with diabetes mellitus","volume":"27","author":"Zawada AE","year":"2018","unstructured":"Zawada AE, Moszak M, Skrzypczak D, Grzymis\u0142awski M. Gastrointestinal complications in patients with diabetes mellitus. Adv Clin Exp Med. 2018, 27:567-72. 10.17219\/acem\/67961","journal-title":"Adv Clin Exp Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-6196(12)60606-5","article-title":"Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment","volume":"68","author":"Valdovinos MA","year":"1993","unstructured":"Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc. 1993, 68:691-702. 10.1016\/s0025-6196(12)60606-5","journal-title":"Mayo Clin Proc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3827301","article-title":"Diabetic enteropathy: from molecule to mechanism-based treatment","volume":"2018","author":"Meldgaard T","year":"2018","unstructured":"Meldgaard T, Olesen SS, Farmer AD, et al.. Diabetic enteropathy: from molecule to mechanism-based treatment. J Diabetes Res. 2018, 2018:3827301. 10.1155\/2018\/3827301","journal-title":"J Diabetes Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12330","article-title":"Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions","volume":"26","author":"Yarandi SS","year":"2014","unstructured":"Yarandi SS, Srinivasan S. Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions. Neurogastroenterol Motil. 2014, 26:611-24. 10.1111\/nmo.12330","journal-title":"Neurogastroenterol Motil"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.05.007","article-title":"Delayed gastric emptying is associated with early and long-term hyperglycemia in type 1 diabetes mellitus","volume":"149","author":"Bharucha AE","year":"2015","unstructured":"Bharucha AE, Batey-Schaefer B, Cleary PA, et al.. Delayed gastric emptying is associated with early and long-term hyperglycemia in type 1 diabetes mellitus. Gastroenterology. 2015, 149:330-9. 10.1053\/j.gastro.2015.05.007","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i36.4881","article-title":"Impaired contractility and remodeling of the upper gastrointestinal tract in diabetes mellitus type-1","volume":"13","author":"Fr\u00f8kj\u00e6r JB","year":"2007","unstructured":"Fr\u00f8kj\u00e6r JB, Andersen SD, Ejskj\u00e6r N, Funch-Jensen P, Drewes AM, Gregersen H. Impaired contractility and remodeling of the upper gastrointestinal tract in diabetes mellitus type-1. World J Gastroenterol. 2007, 13:4881-90. 10.3748\/wjg.v13.i36.4881","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.16.1989","article-title":"Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults","volume":"161","author":"Bytzer P","year":"2001","unstructured":"Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001, 161:1989-96. 10.1001\/archinte.161.16.1989","journal-title":"Arch Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306084","article-title":"Gastroparesis: separate entity or just a part of dyspepsia?","volume":"63","author":"Stanghellini V","year":"2014","unstructured":"Stanghellini V, Tack J. Gastroparesis: separate entity or just a part of dyspepsia?. Gut. 2014, 63:1972-8. 10.1136\/gutjnl-2013-306084","journal-title":"Gut"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01623","article-title":"GI dysfunctions in diabetic gastroenteropathy, their relationships with symptoms, and effects of a GLP-1 antagonist","volume":"104","author":"Chakraborty S","year":"2019","unstructured":"Chakraborty S, Halland M, Burton D, et al.. GI dysfunctions in diabetic gastroenteropathy, their relationships with symptoms, and effects of a GLP-1 antagonist. J Clin Endocrinol Metab. 2019, 104:1967-77. 10.1210\/jc.2018-01623","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.14423\/SMJ.0000000000000212","article-title":"Metformin use and the risk of esophageal cancer in Barrett esophagus","volume":"107","author":"Agrawal S","year":"2014","unstructured":"Agrawal S, Patel P, Agrawal A, Makhijani N, Markert R, Deidrich W. Metformin use and the risk of esophageal cancer in Barrett esophagus. South Med J. 2014, 107:774-9. 10.14423\/SMJ.0000000000000212","journal-title":"South Med J"},{"key":"ref22","article-title":"Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth","volume":"24","author":"Virally-Monod M","year":"1998","unstructured":"Virally-Monod M, Tielmans D, Kevorkian JP, et al.. Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab. 1998, 24:530-6.","journal-title":"Diabetes Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i24.2978","article-title":"Small intestinal bacterial overgrowth syndrome","volume":"16","author":"Bures J","year":"2010","unstructured":"Bures J, Cyrany J, Kohoutova D, et al.. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010, 16:2978-90. 10.3748\/wjg.v16.i24.2978","journal-title":"World J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03351.x","article-title":"Relationship between clinical features and gastric emptying disturbances in diabetes mellitus","volume":"70","author":"Bharucha AE","year":"2009","unstructured":"Bharucha AE, Camilleri M, Forstrom LA, Zinsmeister AR. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf). 2009, 70:415-20. 10.1111\/j.1365-2265.2008.03351.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.310","article-title":"Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population","volume":"107","author":"Choung RS","year":"2012","unstructured":"Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol. 2012, 107:82-8. 10.1038\/ajg.2011.310","journal-title":"Am J Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.5.674","article-title":"Hypoglycemia increases the gastric emptying rate in healthy subjects","volume":"18","author":"Schvarcz E","year":"1995","unstructured":"Schvarcz E, Palm\u00e9r M, Aman J, Berne C. Hypoglycemia increases the gastric emptying rate in healthy subjects. Diabetes Care. 1995, 18:674-6. 10.2337\/diacare.18.5.674","journal-title":"Diabetes Care"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.2002.05537.x","article-title":"GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications","volume":"97","author":"Bytzer P","year":"2002","unstructured":"Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002, 97:604-11.","journal-title":"Am J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1294","article-title":"Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study","volume":"27","author":"Cerutti F","year":"2004","unstructured":"Cerutti F, Bruno G, Chiarelli F, Lorini R, Meschi F, Sacchetti C. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. Diabetes Care. 2004, 27:1294-8. 10.2337\/diacare.27.6.1294","journal-title":"Diabetes Care"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.193","article-title":"Autoimmunity: Celiac disease in T1DM-the need to look long term","volume":"8","author":"Rewers M","year":"2011","unstructured":"Rewers M, Eisenbarth GS. Autoimmunity: Celiac disease in T1DM-the need to look long term. Nat Rev Endocrinol. 2011, 8:7-8. 10.1038\/nrendo.2011.193","journal-title":"Nat Rev Endocrinol"},{"key":"ref30","article-title":"Do microbes have a causal role in type 1 diabetes?","volume":"11","author":"Lammi N","year":"2005","unstructured":"Lammi N, Karvonen M, Tuomilehto J. Do microbes have a causal role in type 1 diabetes?. Med Sci Monit. 2005, 11:RA63-9.","journal-title":"Med Sci Monit"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2014.40844","article-title":"Coexistence of coeliac disease and type 1 diabetes","volume":"9","author":"Szaflarska-Pop\u0142awska A","year":"2014","unstructured":"Szaflarska-Pop\u0142awska A. Coexistence of coeliac disease and type 1 diabetes. Prz Gastroenterol. 2014, 9:11-7. 10.5114\/pg.2014.40844","journal-title":"Prz Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-002-0923-5","article-title":"Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus","volume":"45","author":"Valerio G","year":"2002","unstructured":"Valerio G, Maiuri L, Troncone R, Buono P, Lombardi F, Palmieri R, Franzese A. Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. Diabetologia. 2002, 45:1719-22. 10.1007\/s00125-002-0923-5","journal-title":"Diabetologia"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia A","year":"2013","unstructured":"Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013, 108:656-76. 10.1038\/ajg.2013.79","journal-title":"Am J Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.13.1721","article-title":"Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies","volume":"290","author":"Ziegler AG","year":"2003","unstructured":"Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA. 2003, 290:1721-8. 10.1001\/jama.290.13.1721","journal-title":"JAMA"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo P","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346:1221-31. 10.1056\/NEJMra011775","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0279","article-title":"Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene","volume":"58","author":"Kantartzis K","year":"2009","unstructured":"Kantartzis K, Peter A, Machicao F, et al.. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes. 2009, 58:2616-23. 10.2337\/db09-0279","journal-title":"Diabetes"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly KL","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005, 115:1343-51. 10.1172\/JCI23621","journal-title":"J Clin Invest"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2011.12.005","article-title":"Screening for liver fibrosis by using FibroScan(\u00ae) and FibroTest in patients with diabetes","volume":"44","author":"de L\u00e9dinghen V","year":"2012","unstructured":"de L\u00e9dinghen V, Vergniol J, Gonzalez C, et al.. Screening for liver fibrosis by using FibroScan(\u00ae) and FibroTest in patients with diabetes. Dig Liver Dis. 2012, 44:413-8. 10.1016\/j.dld.2011.12.005","journal-title":"Dig Liver Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01031-8","article-title":"Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes","volume":"42","author":"Cipponeri E","year":"2019","unstructured":"Cipponeri E, Vitturi N, Mariano V, et al.. Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes. J Endocrinol Invest. 2019, 42:1099-107. 10.1007\/s40618-019-01031-8","journal-title":"J Endocrinol Invest"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2015.04.002","article-title":"Rapid reversal of liver steatosis with life style modification in highly motivated liver donors","volume":"5","author":"Choudhary NS","year":"2015","unstructured":"Choudhary NS, Saraf N, Saigal S, et al.. Rapid reversal of liver steatosis with life style modification in highly motivated liver donors. J Clin Exp Hepatol. 2015, 5:123-6. 10.1016\/j.jceh.2015.04.002","journal-title":"J Clin Exp Hepatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez E","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al.. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015, 149:367-78. 10.1053\/j.gastro.2015.04.005","journal-title":"Gastroenterology"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2015.1534","article-title":"Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial","volume":"150","author":"Courcoulas AP","year":"2015","unstructured":"Courcoulas AP, Belle SH, Neiberg RH, et al.. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015, 150:931-40. 10.1001\/jamasurg.2015.1534","journal-title":"JAMA Surg"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-012-0677-1","article-title":"Impact of weight-loss surgery and diabetes status on serum ALT levels","volume":"22","author":"Xourafas D","year":"2012","unstructured":"Xourafas D, Ardestani A, Ashley SW, Tavakkoli A. Impact of weight-loss surgery and diabetes status on serum ALT levels. Obes Surg. 2012, 22:1540-7. 10.1007\/s11695-012-0677-1","journal-title":"Obes Surg"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.11.6095","article-title":"High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry","volume":"84","author":"De Block CE","year":"1999","unstructured":"De Block CE, De Leeuw IH, Van Gaal LF. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry. J Clin Endocrinol Metab. 1999, 84:4062-7. 10.1210\/jcem.84.11.6095","journal-title":"J Clin Endocrinol Metab"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2134","article-title":"Autoimmune gastritis in type 1 diabetes: a clinically oriented review","volume":"93","author":"De Block CE","year":"2008","unstructured":"De Block CE, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab. 2008, 93:363-71. 10.1210\/jc.2007-2134","journal-title":"J Clin Endocrinol Metab"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/13813450802008455","article-title":"Type 2 diabetes mellitus as risk factor for colorectal cancer","volume":"114","author":"Berster JM","year":"2008","unstructured":"Berster JM, G\u00f6ke B. Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem. 2008, 114:84-98. 10.1080\/13813450802008455","journal-title":"Arch Physiol Biochem"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/595649","article-title":"Exocrine pancreatic insufficiency in diabetic patients: prevalence, mechanisms, and treatment","volume":"2015","author":"Piciucchi M","year":"2015","unstructured":"Piciucchi M, Capurso G, Archibugi L, Delle Fave MM, Capasso M, Delle Fave G. Exocrine pancreatic insufficiency in diabetic patients: prevalence, mechanisms, and treatment. Int J Endocrinol. 2015, 2015:595649. 10.1155\/2015\/595649","journal-title":"Int J Endocrinol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i22.2699","article-title":"Which factors determine exocrine pancreatic dysfunction in diabetes mellitus?","volume":"25","author":"Altay M","year":"2019","unstructured":"Altay M. Which factors determine exocrine pancreatic dysfunction in diabetes mellitus?. World J Gastroenterol. 2019, 25:2699-705. 10.3748\/wjg.v25.i22.2699","journal-title":"World J Gastroenterol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2010.tb04000.x","article-title":"Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations","volume":"193","author":"Toouli J","year":"2010","unstructured":"Toouli J, Biankin AV, Oliver MR, Pearce CB, Wilson JS, Wray NH. Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations. Med J Aust. 2010, 193:461-7. 10.5694\/j.1326-5377.2010.tb04000.x","journal-title":"Med J Aust"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/71272-an-emerging-facet-of-diabetes-mellitus-the-nexus-of-gastrointestinal-disorders","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T12:08:49Z","timestamp":1708690129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/71272-an-emerging-facet-of-diabetes-mellitus-the-nexus-of-gastrointestinal-disorders"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.18245","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,24]]}}}